Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. S4 Ar2c3
Griffin C et al. (2025)
|
Xtr Wt + sf3b4 CRISPR
NF29/30 (in situ hybridization)
|
|
|
|
Fig. S4A r3c3
Griffin C et al. (2025)
|
Xtr Wt + sf3b4 CRISPR
NF35/36 (in situ hybridization)
|
|
|
|
Fig. 3 F c3
Berger H et al. (2024)
|
Xla Wt + fbrsl1 MO (sb)
NF24 (in situ hybridization)
|
|
|
|
Fig. 2 A
Ismail T et al. (2024)
|
Xla Wt +PFOS
NF35/36 (in situ hybridization)
|
|
|
No Image
|
Fig. 8A
Flach H et al. (2022)
|
Xla Wt + glyphosate [121.5]
NF20 (in situ hybridization)
|
|
|
No Image
|
Fig.8BC
Flach H et al. (2022)
|
Xla Wt + glyphosate [121.5]
NF28 (in situ hybridization)
|
|
|
No Image
|
Fig. 8A
Flach H et al. (2022)
|
Xla Wt + glyphosate [243]
NF20 (in situ hybridization)
|
|
|
No Image
|
Fig. 8BC
Flach H et al. (2022)
|
Xla Wt + glyphosate [243]
NF28 (in situ hybridization)
|
|
|
|
Fig.S3.B,C
Wang H et al. (2021)
|
Xla Wt + fermt2 MO
NF32 (in situ hybridization)
|
|
|
|
Fig. 7 D G
Schwenty-Lara J et al. (2019)
|
Xla Wt + kmt2d MO
NF28 (in situ hybridization)
|
|
congenital heart disease
Kabuki syndrome
|